AboulkerP., BennasayagE.: Le traitement de la papillomatose vésicale par l'ablation subtotale de la muquense ou cystendérèse. J. d'Urol., 77; 629–633 (1971).
2.
AboulkerP.: Les lesions de l'uretère juxta-vésicale dans le chirurgie endoscopique de la vessie. J. d'Urol., 82; 879–881 (1976).
3.
AlfthanO., SuominenR.: Intravesical therapy with adriamycin. In: Diagnostics and treatment of superficial urinary bladder tumors. WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 95–98, Stockholm 1978.
4.
AlthausenA. F., ProutG. R.Jr., DalyJ. J.: Non invasive papillary carcinoma of the bladder associated with carcinoma in situ. J. Urol., 116; 575–580 (1976).
5.
AmarA. D.: Ureterovesical junction ostruction following transurethral resection. Brit. J. Urol., 37; 303–313 (1965).
AnderssonL.: Diagnostic measures and tumour categorization. In: Diagnostics and treatment of superficial urinary bladder tumors. WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 11–15, Stockholm 1978.
8.
AnderssonL.: Surgical management of superficial urinary bladder tumours. In: Diagnostic and treatment of superficial urinary bladder tumours, WHO collaborating centre for research and treatment of urinary bladder cancer, p. 17–20, Stockholm1978.
9.
AndersonC. K.: Pathological classification of urological tumours, 1978.
10.
AuvertJ.: Comunicazione personale.
11.
BadenochA. W.: Tumours of the bladder. The Practitioner: Symposium of genito-urinary disorders.177; 267–276 (1956).
12.
BadenochA. W.: Advances in urology. The Practitioner: Symposium on advances in treatment.191; 460–464 (1963).
13.
BakerR.: The accuracy of clinical VS surgical staging. J.A.M.A., 206; 1770–1773 (1968).
14.
BandhauerK.: Diagnostik und Therapie des fortgeschrittenen Blasenkarcinoms. Helv. Chir. Acta, 40; 421–426 (1973).
15.
BandhauerK.: La resection transurétrale palliative associée à l'irradiation à haut voltage dans le cancer inopérable de vessie. Helv. Chir. Acta, 40; 421 (1973).
16.
BanksM. D., PontesJ. E., IzbickiR. M., PierceT. M.: Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J. Urol., 188; 757–760 (1977).
17.
BarnesR. W., BersmanR. T.: HadleyH. L., LoveD.: The results of endoscopic surgical treatment of bladder tumors. XIII Cong. Soc. intern. Urol. ed. by FergussonF. D., E. & S. Livingstone Ltd., vol. 2, pag. 122, London1964.
18.
BarnesR. W., BergmanR. T., HadlevH. L., LoveD.: Control of Madder tumors by endoscopic surgery. J. Urol., 97; 864 (1967).
19.
BarnesR. W.: Bladder tumours treated by endoscopic surgery: long term results. Intern. Urol. & Nephrol., 6; 183 (1974).
20.
BarnesR. W., DickA. L., HadleyH. L., JohnsonO. L.: Survival following transurethral resection of bladder carcinoma. Cancer Res.37; 2895–2897 (1977).
21.
BarnesR.: HadleyH., DickA., JohnstonO., DewterJ.: Changes in grade and stage of recurrent bladder tumours. T. Urol., 118; 177 (1977).
22.
BartoloD. C. C., ParsonM. A., WilliamsJ. L.: treatment of infiltrating bladder carcinoma. Brit. J. Urol., 52; 107–111 (1980).
23.
BeerE.: Traitement des papillomes benins de la vessie au moyen du courant de haute frequence introduit dans la vessie à l'aide d'un cystoscope. J. d'Urol., 3; 677 (1913).
24.
BernacchiF.: Considerazioni sulla terapia endoscopica dei papillomi vescicali situati in prossimità degli osti ureterali. Urologia, 53; 612–615 (1976).
BoydP. T. R., BurnandK. G.: Site of bladder-tumour recurrence. Lancet, 30; 1290–1292 (1974).
27.
BonninN. J.: Extended partial cystectomy in the management of bladder carcinoma rationale and case selection. Proc. Urol. Soc. Australasia, Twenty-fourth annual general meeting, Sydney 1981.
28.
BottiC., OlmiR., BorelliG., BertoniV.: Osservazione e trattamento di 328 casi di tumori vescicali. Minerva urol., 27; 249–255 (1975).
29.
BowlesW. T., SilberI.: Carcinoma of the bladder: a computer analysis of 516 patients. T. Urol.107; 245–247 (1972).
30.
BrannanW., OchsmerM. G., FuschierH.Jr., LandryG. R.: Partial cystectomy in the treatment of transitional cell carcinoma of the bladder. J. Urol., 119; 213–215 (1978).
31.
BrenezJ.: La résection endoscopique. Atti 37° Cong. Soc. Belga Urol., Bruxelles 2–4 giugno 1972. Acta Urol. Belgica.41; 61–64 (1973).
32.
BrischiG., PinziN.: Risultati preliminari di uno studio clinico-patologico su 850 cistectomie nel cancro della vescica. Atti 51° Congr. S.I.U., Trieste 1978.
33.
BrischiG., PinziN., Di CelloV., PonchiettiR., FiorelliC.: Carcinoma della vescica: risultati a distanza di 850 cistectomie. Atti 51° Congr. Soc. It. Urol., Trieste 1978.
34.
WahernBritta, EdsmyrF., ZimmermanR.: CEA determinations in urine and serum of adriamycin-treated patients with bladder carcinoma. In: Diagnostics and treatment of superficial urinary bladder tumors.WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 59–62, Stockholm1978.
35.
BurnsideK.: Technique and difficulties of transurethral resection of bladder tumours. Abstracts of the Proc. Urol. Soc. of Australasia, 24th Annual General Meeting, Sydney 1971.
36.
CarmaiaG.: Chemioterapia sistemica delle neoplasie vescicali infiltranti. In: The tumours of genito-urinary apparatus. Erice 1976, Edited by Pavone-MacalusoM., pp. 229–234. COFESE, Palermo1977.
37.
CaramiaG., RizzoF. P., VecchioniM., Pavone-MacalusoM.: Sull'impiego in uroiogia di un antibiotico ad azione antiblastica (doxorubicina o adriamicina). Parte 1: Kisultati clinici dopo due anni di esperienza. Urologia, 40; 427–442 (1973).
38.
CarterS. K., WassemanT. H.: The chemoterapy of urologic cancer. Cancer, Suppl. 36, 729–747 (1975).
39.
CatalonaW. J.: Bladder carcinoma. J. Urol., 123; 35 (1978).
40.
CavazzanaP.: Classificazione comparativa tra i tumon epiteliali della vescica. Urologia, 44; 603–607 (1977).
41.
ChatelainC., DenisM.: Une série de 200 tumeurs malignes de vessie. Résultats du traitement chirurgical. J. d'Urol., 72; 291 (1966).
42.
ChatelainC., MoarbesA., KüssR.: Avenir des opérés après cystectomie totale pour cancer infiltrant. J. d'Urol., 79; 84 (1973).
43.
ChatelainC., MathieuF., RichardF., OrsoniJ. L., GoutiersD., FourcadeR., AllegreJ. P., KüssR.: Le traitement endoscopique isolé des tumeurs superficielles de la vessie: un étude de 232 cas. SAminaires d'Uro-Néphrologie Pitié-Salpêtrière Sixieme Série 1980. Masson éd., Paris1980.
44.
ChisolmG. D., HinmarshJ. R., HowatsonA. G., WebbJ. N., BusuttilA., HargreaveT. B., NewsamJ. E.: TNM (1978) in bladder cancer use and abuse. Brit. J. Urol., 52; 500–505 (1980).
Cifuentes DelatteL.: Frequencia de las neoplasie vesicales en ambos sexos. Una encuesta entre los urólogos españoles de Urologia. Arch. esp. Urol., 27; 18 (1975).
47.
Cifuentes DelatteL., Lorenzo GarciaA.: Frecuencia de las neoplasia vesicales en España (1953–1973). In: Problemas actuales de uroiogia. Madrid 1974.
48.
Cifuentes DelatteL.: Tecnica de la resection endoscopica de las neoplasias de la vejiga. In: Problemas actuales de Urologia. Madrid 1974.
49.
Cifuentes DelatteL.: Statistique de 1000 tumeurs vésicales. J. d'Urol., 77; 1–2 (1971).
50.
Cifuentes DelatteL., OlivaH., NavarroV.: Intrahepithelial carcinoma of the bladder. Urol. Intern., 25; 169 (1970).
51.
Cifuentes DelatteL.: Técnica de la resección endoscopica de las neoplasia vesicales. In: Problemas actuales de Urologia, p. 30. Ed. Salvat, Barcelona1977.
52.
ClarkP. B.: Radical cystectomy for carcinoma of the bladder. Brit. J. Urol., 50; 492–495 (1978).
53.
CollanY., MäkinenJ., HeikkennenA.: Histological grading of transitional cell tumours of the bladder. Value of histological grading (WHO) in prognosis. Eur. Urol., 5; 311 (1979).
54.
ConollyJ. G.: Some arguments against the use of mucosal stripping in the treatment of recurrent, superficial cancer of the bladder. J. Urol., 107; 49 (1972).
55.
CooperT. P., WheelisR. F., CorreaR. J., GibbonsR. P., MasonJ. T., CummingsK. B.: Random mucosal biospies in the evaluation of patients with carcinoma of the bladder. J. Urol., 117; 46–48 (1977).
56.
Cortes CausinoJ. M., Moreno CaparrosA., Oliva AldamizH., Cifuentes DelatteL.: Carcinoma «in situ» de vejiga. Presentation de seis casos. Arch. Esp. Urol., 30; 537–560 (1977).
57.
CreevyC. D.: Preventing stimulation of the obturator nerve during transurethral resection. J. Urol., 101; 368 (1969).
58.
CummingsK. B., MasonJ. T., CorreaR. J., GibbonsR. P.: Segmental resection in the management of bladder carcinoma. J. Urol., 119; 56 (1978).
59.
Dell'AdamiG.: Resezione transuretrale dei tumori vescicali. Urologia, 40; 158–170 (1973).
60.
Dell'AdamiG., SesennaR: Rilievi statistici e tecnici di chirurgia endoscopica delle neoplasie vescicali. Urologia, 30; 34 (1963).
61.
DekernionJ. B.: The chemotherapy of advanced bladder carcinoma. Cancer Res., 37; 2771–2774 (1977).
DenisR.: Les complications de la résection endoscopique. Atti 37° Congr. Soc. Belga Urol., Bruxelles 24 giugno 1972, in Acta Urol. Belgica, 41; 74–77 (1973).
64.
DickA., BarnesR., HadleyH., BergmanR. T., NinanC. A.: Complications of transurethral resection of bladder tumours: Prevention, recognition and treatment. J. Urol., 124; 810–811 (1980):
65.
DicksonJ. A., CalderwoodS. K.: Temperature range and selective heat sensivity of tumors. New York Ac. Conference: Thermal characteristics of tumors applications in detection and treatment, p. 13, 1979.
66.
Di PietroS., CunsoloA., De PaoloG. M.: Prime esperienze con l'adriamicina nella terapia antiblastica distrettuale mediante infusione arteriosa. Giorn. Clin. Med., 50; 1144–1149 (1969).
67.
DonovanH.: A consideration of the operation of partial cystectomy for bladder neoplasms. Brit. J. Urol., 31; 95 (1959).
68.
DrozJ. P., AyedF. B., PascalB., BeurtonD., CukierJ., AmielJ. L.: Essais de traitments dans les cancers de la vessie inopérables. J. d'Urol., 86; 479 (1980).
69.
EdsmyrF.: The biology and clinical management of bladder cancer. Ed. CooperE.H., WilliamsR. G., p. 229–250. Blackwell Scientific Publ., London1975.
70.
EdsmyrF., BerlinT., BomanJ., DuchekM., EspostiP. L., GustafsonH., WikstromH.: Intravesical therapy with adriamycin in patients with superficial bladder tumours. In: Diagnostics and treatment of superficial urinary bladder tumors.WHO, Collaborating centre for research and treatment of urinary bladder cancer, p. 45–53, Stockholm1978.
71.
EinsenbergR. B., RothR. B., SchweninsbergM. H.: Bladder tumors and associated proliferative mucosal lesions. J. Urol., 84; 544 (1960).
72.
EksborgS.: Measurements of plasma levels of adriamycin and adriamycinol after intravesical instillation of adriamycin. In: Diagnostic and treatment of superficial urinary bladder tumors.WHO, Collaborating centre for research and treatment of urinary bladder cancer, p. 55–58, Stockholm1978.
73.
ElliotG. B.: Denuding cystitis and in situ urothelial carcinoma. Arch. Pathol., 96; 91–94 (1973).
74.
EnglandH. R., ParisA.M.I., BlandyJ. P.: The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Brit. J. Urol., 53; 593–597 (1981).
75.
EORTC Urological Group B (RobinsonM. R. G., SmithP. H., Pavone-MaccalusoM., MulderJ. H., Martinez-PiñeiroJ. A., Cifuentes-DelatteL., BonoA., and GlashanR. W.: The treatment of advanced carcinoma of the bladder with a combination of adriamycin and 5-fluorouracil. Eur. Urol., 3; 276–278 (1977).
76.
EspostiP. L., TribukaitB., GustafsonH.: Effects of local treatment with adriamycin in carcinoma in situ of the urinary bladder: cell morphology and DNA analysis for quantification of malignant cells. In: Diagnostics and treatment of superficial urinary bladder tumors. WHO, Collaborating centre for research and treatment of urinary bladder cancer, p. 71–78, Stockholm1978.
77.
EvansR. A., TexterJ. H.Jr.: Partial cystectomy in the treatment of bladder cancer: 25 year period. J. Urol., 114; 391–393 (1975).
78.
FarrowG. M., UtzD. C., RifeC. C., GreeneF.: Clinical observations on sixty-nine cases of in situ carcinoma of the urinary bladder. Cancer Res., 37; 2794–2798 (1977).
79.
FiorelliC., MazzoniM., TentiS., DurvalA., Cola FranceschiM.: Caratteristiche fisiche dei Laser usati in Urologia. Urologia, 48; 958 (1981).
80.
FiorelliC., TentiS., DurvalA., MazzoniM., Di CelloV., CariniM., TaddeiG. L.: Caratteristiche d'uso del Laser sulla parete vescicale. Urologia, 48; 967 (1981).
81.
FlacheneckerG., FastenmeierK.: High frequency current effects during transurethral resection. J. Urol., 122; 336–341 (1979).
82.
FolkmanJ.: The vascularization of tumors. Sci. Amer., 59–73 (1976).
83.
FolkmanJ., CotranR.: Relation of vascular proliferation to tumor growth. Intern. Rev. Exp. Pathol., 207–248 (1976).
84.
FontaneilaV. A., AntonacciC., FarinaU., CatanzaroF., ZanolloA.: Cistectomia versus T.U.R. nel carcinoma vescicale. Urologia, 47; 392–396 (1980).
85.
FournierR., VivilleC.: La resection endoscopique dans le traitement des epitheliomas excréto-urinaires non infiltrants de la vessie. à propos de 146 resections endoscopiques sur 53 malades. J. d'Urol., 83; 389–396 (1977).
86.
FreedS. Z.: Vesico-ureteral reflux following transurethral resection of bladder tumours. J. Urol., 116; 184–187 (1976).
87.
FreiE.III, LuceJ. K., MiddlemanE.: Clinical trials of adriamycin. In: International Symposium on Adriamycin. Edited by CartenS. K., Springer-Verlag, Berlin-New York, 1972, p. 153–164.
88.
FrickJ.: Klinik, Diagnostik und Therapie des Blasencarcinoms. Z. Allgem. Med., 46; 73 (1970).
89.
FossebergE., SanderS.: Topical adriamycin treatment of superficial bladder tumours. In: Diagnostics and treatment of superficial urinary bladder tumors.WHO, Collaborating centre for research and treatment of urinary bladder cancer, p. 99–101, Stockholm1978.
90.
GherardiL., XausaD., TamaiA.: L'interruzione del muscolo trigonale dopo prostatectomia come probabile causa di reflusso vescico-ureterale: con-trolli cistografici e cistomanometrici pre- e post-operatori. Urologia, 47; 797 (1980).
91.
GibsonT. E.: Treatment of bladder tumors with the McCharty resectoscope. J. Urol., 34; 8 (1935).
92.
GilbertH. A., LoganJ. L., KaganA. R., FriedmanH. A., CoveJ. K., FoxM., MuldonT. M., LonniY.W., RoweJ. H., CooperJ. F., NussbaumH., ChanP., RaoA., StarrA.: The natural history of papillary transitional cell carcinoma of the bladder and its treatment in an unselected population on the basis of histologic grading. J. Urol., 119; 488–492 (1978).
93.
GiovanellaB. C., WilliamsL. J., StehlinJ. S.Jr., MorganA. C.: Selective lethal effect of supranurmal temperatures on human neoplastic cells. Cancer Res., 36; 3944–3950 (1976).
94.
GottfriesA., NilssonS., SundinT., ViklundL. G.: Late effects of transurethral resection of bladder tumours at the ureteric orifice. Scand. J. Urol. & Nephrol., 9; 32–35 (1975).
95.
GreeneF. L., YalowitzP. A.: The advisability of concomutant transurethral excision of vesical neoplasm and prostatic hyperplasia. J. Urol., 107; 445–447 (1972).
96.
GrossmanH. B.: Current therapy of bladder carcinoma. J. Urol., 121; 1 (1979).
97.
GullinoP. M.: Angiogenesis and oncogenesis. J. Nat. Can. Inst., 61; 639–643 (1978).
98.
GunterD.: The results and failures of transurethral resection of bladder tumours. Proceedings of the urological Society of Australasia. Twenty-fourth annual general meeting, Sydney 1971.
99.
GustafsonH., TribukaitB., EspostiP. L.: Quantitative flow-microfluorometric analysis of DNA in cells from superficial tumours of the urinary bladder. In: Diagnostics and treatment of the superficial urinary bladder tumors.WHO, Collaborating centre for research and treatment of urinary bladder cancer, p. 63–69, Stockholm1978.
100.
HancockR. A.: Modified position for transurethral resection of bladder tumors in women. J. Urol., 75; 83 (1956).
101.
HansenR. I., NerstrmB., DjurhunsJ. C., LundF. L.: Late results from mucosal denudation for urinary bladder papillomatosis. Acta Chir. Scand., 472; 73–76 (1976).
102.
HarveyP., BrunetM.: à propos de 363 tumeurs de vessie; étude de leurs caractères et tentative d'une classification simplifiée afin de guider le traitement. Ann. d'Urol., 6; 173–180 (1972).
103.
HelmsteinK., HelmsteinK.Jr.: Traitement du cancer de la vessie par la technique de la compression hydrostatique. Rapport de 76 cas. J. d'Urol., 81; 12 (1975).
104.
HeneyN. M., SzyfelbeinW. M., DalyJ. J., ProutG. R., BredinH. C.: Positive urinary cytology in patients without evident tumor. J. Urol., 117; 223–224 (1977).
105.
HeneyN. M., DalyY., ProutG. R., NiehP. T., HeaneyJ. A., TrebeckN. E.: Biopsy apparently normal urothelium in patients with bladder carcinoma. J. Urol., 120; 559–560 (1978).
106.
HietalaS. O.: Angiographic abnormalities in the urinary bladder wall after irrigation. Clin. Invest. Acta Radiol. Suppl., 328; 54–73 (1973).
107.
HinmanF.: Recurrence of bladder tumors by surgical implantation. J. Urol., 75; 695 (1956).
108.
HofstetterA., FrankF.: The neo-dynium - YAG Laser in Urology.Roche Sci. Service ed. «Roche» Basel, Switzerland1980.
109.
HoffstetterA., RothenbergerK., KeiditschE., FrankF., PenseiJ., BöweringR., Henneberger: The efficienency of the neodymium-Yag Laser in urinary bladder treatment. Urology, 10; 18–20 (1981).
110.
HunltengrenN., OrellS. R.: Widespread in situ carcinoma of the bladder with multifocal early invasion. Report of a case subjected to total cystectomy. Scand. J. Urol. & Nephrol., 5; 273 (1971).
111.
IzbickiR. M., PontesE., Vaitke ViciusV. K.: Adriamycin bladder instillation (ABI). Proc. AACR/ASCO, Abst. C-297, Toronto 1976.
112.
JacobellisU., Tal-larigoA.: Considerazioni su 176 tumori vegetanti della vescica trattati con resezione endoscopica. Atti 50° Congr. Soc. It. Urol., Vol. 2°, Ancona 1977.
113.
JacobiG. H., KuthK. H., KlippelK. F., HohenfellnerR.: On the biological behaviour of the T1 transitional cell tumors of the urinary bladder and initial results of the prophylactic use of topical adriamycin under controlled and randomized conditions. In: Diagnostics and treatment of superficial urinary bladder tumors.WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 83–94, Stockholm1978.
114.
JacobsonB., SundinT.: Vesico-ureteral reflux following slitting of the ureteral orifice. Acta Chir. Scand., 125; 261–266 (1963).
115.
JellinghansW.: Evaluation of bladder tumors by endoscopic procedures. Endoscopy, 4; 231–235 (1979).
116.
JewettH. J., StrongG. H.: Infiltrating carcinoma of the bladder. Relation of depth of penetration of the bladder wall to incidence of local extension and metastases. J. Urol., 55; 366–372 (1946).
117.
JewettH. J.: Carcinoma of the bladder: influence of depth of infiltration on the five year results following complete extirpation of the primary growth. J. Urol., 67; 672 (1952).
118.
JewettH. J.: Simple cystectomy and segmental resection for cancer of the bladder. J. Urol., 70; 620 (1953).
119.
JewettH. J.: The diagnosis and treatment of carcinoma of the bladder. Pennsylvania Med. J., 60; Ali (1957).
120.
JewettH. J.: Carcinoma of the bladder: development and evaluation of current concepts of therapy. J. Urol., 82; 92 (1959).
121.
JewettH. J.: Carcinoma of the bladder: diagnostic appraisal and choice of treatment. J. Urol., 86; 572 (1961).
122.
JewettH. J., KingR. L., ShelleyW. M.: A study of 365 cases of infiltrating bladder cancer. Relation of certain pathological characteristics to prognosis after extirpation. J. Urol., 92; 668–678 (1964).
123.
JewettH. J.: Conservative treatment versus radical surgery for superficial cancer of bladder. J.A.M.A., 206; 2720 (1968).
124.
JewettH. J.: Cancer of the bladder: diagnosis and staging. Cancer, 32; 1072 (1973).
125.
JewettH. J.: Comments on the staging of invasive bladder cancer: Two B's or not two B's: That is the question. J. Urol., editorial, 119; 39 (1978).
126.
JohnsonD. E.: Surgery for carcinoma of the urinary bladder. Cancer Treat. Rev., 1; 271–283 (1974).
127.
JohnsonD. E., SamuelsM. L.: Cancer of genitourinary tract. The University of Texas system Cancer center. M. D. Anderson Hospital and Tumor Institute 23rd Annual Clinical Conference on Cancer. Raven Press, New York1979.
128.
JonesH. C., SwinneyJ.: The treatment of tumours of the bladder by transurethral resection. Brit. J. Urol., 34; 215 (1962).
129.
JoseJ. S.: Extended partial cystectomy in the management of bladder carcinoma: Technique and results. Proceedings ot the urological Society of Australasia. Twenty-fourth annual general meeting, Sydney 1981.
130.
KanoM., JwasakiH.: Non papillary carcinoma in situ of the blander: a clinico-pathologic study of 2 cases treated with radical cysto-prostatourethrectomy. J. Urol., 122; 116–120 (1979).
131.
KaplanJ. H., McDonaldJ. R., ThompsonG. J.: Multicentric origin of papillary tumors of the urinary tract. J. Urol., 66; 792 (1951).
132.
KavadisC.: Analyse d'une statistique de papillomes vésicaux recidivants, J. d'Urol., 77; 729–736 (1971).
133.
KennyG. M., HardnerG. J., MooreR. M., MurpluyG. P.: Current results from treatment of stages C and D bladder tumours at Roswell Park Memorial Institute. J. Urol., 107; 56–59 (1972).
134.
KieperJ. H.: Bladder tumor recurrence in the urethra: a warning. J. Urol., 69; 652 (1953).
135.
KishiK. W., HirotaT., MatsumotoK., KakizocT., MuraseT., FujitaJ.: Carcinoma of the bladder: a clinical and pathological analysis of 87 autopsy cases. J. Urol., 125; 36–39 (1981).
136.
KitamuraK., KataokaK., FujokaH., KashiwaiK.: Transurethral resection of a bladder tumor by the use of polypectomy snare. J. Urol., 124; 808–809 (1980).
137.
KoganS. J., FreedS. Z.: Postoperative course of vesicoureteral reflux associated with benign obstructive prostatic disease. J. Urol., 112; 322 (1974).
138.
KossL. G., EsparanzaM., TiamsonE. M., RobbinsM. A.: Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. J.A.M.A., 227; 381 (1974).
139.
KossL. G.: Tumors of the urinary bladder. Atlas of tumor Pathology: second Series, Fasc. 11, A.F.I.P., Washington1975.
140.
KossL. G.: Mapping of the urinary bladder: its impact on the concepts of bladder cancer. Human Pathology, 10; 533–538 (1979).
141.
LaneV.: Comunicazione personale.
142.
LangkopjB., FreitagJ., MewisF.: Klinish-esperimentelle angiographische Untersuchungen über das Verhalten von normalen Blasengefässen und von Tumorgefässen gegenüber erhölten intravesikalem. Dtsch. Z. Nephrol., 71; 97–106 (1978).
143.
LaplanteM., BriceM.: The upper limits of hopeful application of radical cystectomy tor vesical carcinoma: does nodal metastasis always indicate incurability? J. Urol., 109; 261 (1973).
144.
LarkingJ. M.: A clinical investigation of total body hypertemy as cancer therapy. Cancer Res., 39; 2252 (1979).
145.
LessingJ. A.: Bladder cancer: early diagnosis and evaluation of biologic potential. A review of newer methods. J. Urol., 120; 1–5 (1978).
146.
LeonigS.: Urinary cytology and bladder biopsy in patients with bladder cancer. Urology, 11; 591–595 (1978).
147.
LoeningS., NarayanaA., YoderL., SlymesS., WeinteinS., PenickG., CulpD.: Factors influencing the recurrence rate of bladder cancer. J. Urol., 123; 29–31 (1980).
148.
LongR. T. L., GrummonR. A., SprattJ. S.Jr., Perez MesaC.: Carcinoma of the urinary bladder (comparison with radical, simple and partial cystectomy and intravesical formalin). Cancer, 29; 98 (1972).
149.
MagriJ.: Partial cystectomy: a review of 104 cases. Brit. J. Urol., 34; 74 (1962).
150.
MalloN., VicenteJ.: Diagnostic and therapeutic patterns of bladder tumors. Eur. Urol., 2; 96–98 (1975).
151.
MaquinaryCh., BouffiouxCh.: Les complications de la résection endoscopique. 37me Congr. Soc. Belge d'Urol., Bruxelles 2–4 Juin 1972. Acta Urol. Belgica, 41; 57–60 (1972).
152.
MarbergerH., FrickJ.: Grenzen, Vorteile und Gefahren dez transurethralen Resektion bei Blasen Carcinomen. 14th Biennal Intern. Congr. Intern. College of Surgeons, p. 227–238, Vienna 1964.
153.
MarbergerH.: Die transurethrale Resektion beim Blasenkarcinom. Langebecks. Arch. Chir., 319; 862 (1967).
154.
MarbergerH., MarbergerM.Jr., DecristoforoA.: The current status of transurethral resection in the diagnosis and therapy of carcinoma of the urinary bladder. Intern. Urol. & Nephrol., 4; 35–44 (1972).
155.
MarbergerH.: TUR o resezione a cielo aperto? Quando e perché. Atti Convegno di Senigallia, Ancona, 6; 19–21 (1981).
156.
MarquardtH. D.: Technik der transurethralen Tumor-Koagulation und Resektion. Urologe A, 1; 163 (1972).
157.
MarshallW. F.: The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasm. J. Urol., 68; 714–723 (1952).
158.
MarshallV. F.: Current clinical problems regarding bladder tumors. In: Bladder tumors: A symposium.J.B. Linpincott, Philadelphia1956.
159.
MarshallV. F., HoldenJ., MaK. T.: Survival of patients with bladder carcinoma treated by simple segmental resection. One hundred twenty three consecutive cases 5 years later. Cancer, 9; 568 (1956).
160.
MarshallV. F., McCarronJ. P.Jr.: The curability of vesical cancer: greater now or then?Cancer Res., 37; 2753–2755 (1977).
161.
Martinez-PiñeiroJ. A.: Tumores vesicales. Relaz. Congreso Español de Urologia, Maggio 1971. Acta Assoc. Esp. Urol., II0, 1 (1971).
162.
Martinez PiñeiroJ. A.: The complications of endoscopic resection. Atti 37° Congr. Soc. Belga Urol., Acta Urol. Belgica, 41; 65–67 (1972).
163.
Martinez PiñeiroJ. A.: La endoscopia de los tumores vesicates. Ill” Corso Monografico de Urologia.Servicio de Urologia Clinica de La Paz, Madrid1970.
164.
Martinez PiñeiroJ. A.: The treatment of carcinoma. Eur. Urol., 1; 68–70 (1975).
165.
Martinez PiñeiroJ. A.: Transurethral resection ot bladder tumours. In: M. Pavone Macaluso: The tumours of genito-urinary apparatus, p. 203–213. COFESE, Palermo1977.
166.
MasinaF.: Mucosal changes in relation to bladder tumours. Brit. J. Urol., 24; 344 (1952).
167.
MasinaF.: Segmental resection for tumors of the urinary bladder: ten year follow-up. Brit. J. Surg., 52; 279 (1965).
168.
MathieuF.: Résultats du traitement du cancer de vessie par l'association R.T.U. et télécobaltothérapie, à propos de 183 cas. J. d'Urol., 72; 336 (1966).
169.
MathieuF., RousseauJ., MathieuG., FantonJ.: Place de la chirurgie endoscopique associée à l'irradiation à haute énergie dans le traitement conservateur du cancer de vessie. Seminaires d'uronéphrologie. Pitié-Spalpêtrière, sixième série, 1980.
170.
MathieuG., MathieuF., RousseauJ., FantonJ.: Cancer de la vessie, survie de 165 cas T1, T2, T3 traités a l'Institut Curie entre 1956 et 1976. Bulletin Cancer, 3; 327 (1979).
171.
MauermeyerW.: Die transurethrale Resection des Blasenkarzinoms: Indikationsteliung, Technik. Urol. Intern., 23; 244–262 (1968).
172.
MauermeyerW.: Eine arbeitssparende Modifikation des Elektroresektionsshafts. Urologe A, 12; 140–142 (1973).
173.
MauermeyerW.: Möglichkeiten und Grenze der transurethralen Behandlung des Blasenkarzinoms. Urologe A, 12; 55–58 (1973).
174.
McAdamW. A. F., JamesW. B.: Vesico-ureteric reflux after transurethral meatotomy. Brit. J. Urol., 54; 120–124 (1967).
175.
McCarronJ. P., MarshallV. F.: The survival of patients with bladder tumors treated by surgery: comparative results of an old and recent series. J. Urol., 122; 322–324 (1979).
176.
MearesE. M.: Non invasive carcinoma of the bladder. J. Urol, 107; 394–395 (1972).
177.
MelamedM. R., GrabstaldH., WhitmoreW. F.Jr.: Carcinoma in situ of bladder: clinico-pathological study of case with a suggested approach to detection. J. Urol, 96; 466 (1966).
178.
MelamedM. R., VontsaN. G., GrabstaldH.: Natural history and clinical behavior of in situ carcinoma of the human urinary bladder. Cancer, 17; 1533 (1964).
179.
MelicowM. M.: Tumors of urinary bladder: a clinico-pathological analysis of over 2500 specimens and biopsies. J. Urol, 74; 798 (1955).
180.
MelicowM. M.: Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J. Urol, 68; 261 (1952).
181.
MelicowM. M.: Tumors of the bladder. Multifaced problem. J. Urol, 112; 467–478 (1974).
182.
MelicowM. M.: Carcinoma in situ: an historical perspective. Urol. Clin. N. Amer., 3; 5 (1976).
183.
MerringC., BeckleyS.: Adjuvant chemotherapy for bladder cancer with doxorubicin hydrochloride and cyclophosphamide. Preliminary report. J. Urol, 119; 62–63 (1978).
184.
MillerA, MitchellJ. P., BrownN. J.: The natural history of bladder tumours. In the Bristol Bladder Tumour Registry. Brit. J. Urol, suppl.41; 17 (1969).
185.
MilnerW. A.: Transurethral biopsy: an accurate method of determining the true malignancy of bladder carcinoma. J. Urol, 61; 917 (1949).
186.
MoloneyP. J., ElliotG. B., McLanghlinM., SinclairA. B.: In situ transitional carcinoma and non specifically inflammed contracting bladder. J. Urol, 111; 162 (1974).
187.
MorabitoR. A., KandzariS. J., MilamD. F.: Invasive bladder carcinoma treated by radical cystectomy. Urology, 14; 478–481 (1979).
188.
MorilloM. M., OrandiA, FernandezM., DraperJ. W.: Vesicoureteral reflux in male adults with bladder neck obstruction. J. Urol, 89; 389 (1963).
189.
MostofiF. K.: A study of 2678 patients with initial carcinoma of the bladder: I. Survival rate. J. Urol, 75; 480 (1956).
190.
MostofiF. K.: A study of 2678 patients with initial carcinoma of the bladder. II. Survival rates in relation to therapy. J. Urol, 75; 492 (1956).
191.
MostofiF. K.: Pathology of cancer of bladder. Acta Un. Intern. Cancer, 18; 611 (1962).
192.
MostofiF. K.: Pathological aspects and spread of carcinoma of the bladder. J.A.M.A, 206; 1764–1769 (1968).
193.
MurphyW. M., NagyG. K., RaoM. K., CoxC.: «Normal» urothelium in patients with bladder cancer. Cancer, 44; 1050–1058 (1979).
194.
NicholsJ. A., MarshallV. F.: Treatment of bladder carcinoma by local excision and fulguration. Bladder Tumors: a symposium, p. 17. J. B. Lippincott Co, Philadelphia1956.
195.
Nitze: Citato da Cifuentes.
196.
NiijimaT.: Intravesical therapy with adriamycin and new trends in the diagnostics and therapy of superficial urinary bladder tumors. In: Diagnostic and treatment of superficial urinary bladder tumors.WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 37–44. Stockholm1978.
197.
NovickA. C., StewartB. H.: Partial cystectomy in the treatment of primary and secondary carcinoma of the bladder. J. Urol., 116; 570 (1976).
198.
O'FlynnJ. D., SmithJ. M., HansonJ. S.: Transurethral resection for the assessment and treatment of vesical neoplasms. A review of 840 consecutive cases. Eur. Urol., 1; 38 (1975).
199.
OkedaK., AmagaiT., OnoeY., KishimotoTo.: Transurethral Laser surgery for bladder tumor. Urology, 10; 11–14 (1981).
200.
OlssonC. A., De Vere WhiteR. W.: Cancer of the bladder. In: Principles and management of urologic cancer. Edited by Nasser Javedpaur National Cancer Institute.
201.
PaganoF., AnselmoG., Cosciani-CunicoS., LemboA.: Cistectomia cupolare delle neoplasie vescicali. Tecnica e risultati. Urologia, 37; 113–118 (1970).
202.
PageB. H., LevisonV. B., CurwenM. P.; The site of recurrence of non-infiltrating bladder tumours. Brit. J. Urol., 50; 237 (1978).
203.
Pavone-MacdusoM.: Chemotherapy of bladder tumours. Urol. Res., 6; 259–262 (1978).
204.
Pavone-MacalusoM., EORTC Genito-Urinary Tract Co-Operative Group A: Single-drug chemotherapy of bladder cancer with adriamycin VM-26 or bleomycin. Eur. Urol., 2; 138–141 (1976).
205.
Pavone-MacalusoM.: Intravesical treatment of superficial (Ti) urinary bladder tumours. A review of a 15–year esperience. In: Diagnostics and treatment of superficial urinary bladder tumors.WHO, collaborating centre for research and treatment of urinary bladder cancer, p. 21–36, Stockholm1978.
206.
Pavone-MacalusoM., GebbiaN., BiandoF., BertoliniS., CaramiaG., RissoF. P.: Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbits. Urol. Res., 4; 9–13 (1976).
207.
Pavone-MacalusoM., RausaL., GebbiaN., BiondoF., ArenaE., RizzoF. P., CaramiaG., TessitoreV.: Sull'impiego in urologia di un antibiotico ad azione antiblastica (doxorubicina o adriamicina). Parte II. Ricerche sperimentali. Urologia, 40; 442–450 (1973).
208.
Pavone-MacalusoM.: Staging chimico e patologico delle neoplasie vescicali. Atti XXIII Corso superiore di Oncologia Clinica: I tumori urologici. Milano 19 Maggio 1981.
209.
Pavone-MacalusoM.: Il trattamento del carcinoma papillare di categoria T1, e del carcinoma in situ della vescica. Atti XXIII Corso superiore di Oncologia Clinica: I tumori maligni, Milano, 19 maggio 1981.
210.
Pavone-MacalusoM.: Possibilità di prevenzione farmacologica delle neoplasie vescicali. Atti XXIII Corso superiore di Oncologia Clinica: I tumori urologici. Milano 19 Maggio 1981.
211.
PascalB., CukierJ.: Evolution des tumeurs malignes superficielles de vessie. A propos de 135 cas. J. d'Urol., 85; 385–397 (1979).
212.
PearseH. D., ReedR.R., HodgesC. V.: Radical cystectomy for bladder cancer. J. Urol., 119; 216 (1978).
213.
PearseH. D., PappesJ. T., HodgesC. V.: Radical cystectomy for bladder cancer: 10 years survival. J. Urol., 109; 623 (1973).
214.
PeressJ. A., WaterhouseK., ColeA. T.: Complication of partial cystectomy in patients with high grade bladder carcinoma. J. Urol., 118; 761 (1977).
215.
Perez CastroE., IglesiasJ. J.: Resección de tumoraciones vesicales con irrigación-succión continua. Arch. Esp. Urol., 30; 43 (1977).
216.
PiccinnoA., ChiumarelloC., PagliaruloA.: La resezione endoscopica nel trattamento dei tumori vegetanti della vescica. Contributo clinico. Urologia, 39; 503–506 (1972).
217.
PiccinnoA., GuidoA., Di RienzoU., BrunoL., Cirillo-MaruccoE.: La resezione endoscopica nel trattamento dei tumori della vescica. Urologia, 44; 647–652 (1977).
218.
PisaniE., Pirozzi FarinaF.: L'iperbarismo nel trattamento delle neoplasie vescicali. XXIX Convegno Soc. Urologi Nord Italia. Urologia, 47; 965 (1980).
219.
PomeranceA.: Pathology end prognosis following total cystectomy for carcinoma of bladder. J. Urol., 44; 451–458 (1972).
220.
Ponce De LeonF., ManavellaG.: Enseñanzos de 200 casos de tumor vesical a los 5 y 10 años del tratamiento endoscopico. An. Fund. Puigvert, 3; 73 (1973).
221.
PotenzoniD., StagniG.: Angiogenesi e angio-architettura tumorale. Arch. It. Urol., 48; 277–287 (1976).
222.
PreutissR. J.: Transurethral excision of huge bladder tumor. J. Urol., 46; 688 (1941).
223.
Protocollo EORTC 30782, 1979.
224.
ProutG. R.Jr.: The surgical management of bladder carcinoma. Urol. Clin. N. Amer., 3; 149–175 (1976).
225.
ProutG. R.Jr.: Bladder carcinoma and a TNM system of classification. J. Urol., 117; 583–590 (1977).
226.
ProutG. R., PamelaP., GriffinB. A., ShipleyW.: Bladder carcinoma and a systemic disease. Cancer, 43; 2532–2539 (1979).
227.
ProutG. R.Jr.: Staging of cancer 1977. American Joint Committee, p. 113–118, Chicago 1977.
228.
QuackelsR.: Les complications de la résection endoscopique. Atti 37° Congr. Soc. Belga Urol., Bruxelles 2–4 Giugno 1972. In: Acta Urol. Belg., 41; 88–102 (1973).
229.
RaatzschH., HackelW., StrietzelM., ZepnickH.: Principien und Ergebnisse der Behandlung des Harnblasen-Karzinoms unter besonderer Berücksichtigung der Kombinierten Therapie. Zschr. Urol., 69; 103 (1976).
230.
RabaiottiA., RossiL., BezziE.: Considerazioni sul valore semeiologico dell'angiografia vescicale. Ateneo parmense, 28; 1–19 (1957).
231.
RavasiniG.: Atti 23° Congresso Soc. It. di Urologia, Palermo 1950.
232.
RavasiniG.: Tumori della vescica. Estratto del Capitolo «Malattie della vescica» in «Trattato Italiano di Urologia», vol. 2°. Ed. Scientifiche, Napoli1951.
233.
RavasiniG.: La cistectomia totale nella terapia dei tumori maligni della vescica. Prog. Terapia, 15; 6–7 (1951).
234.
RavasiniG.: Attuali orientamenti nella cura dei tumori della vescica. Acta Chir. Ital., 13; 1–20 (1957).
235.
RavasiniG., CavazzanaP.: Cancro della vescica: risultati lontani del trattamento chirurgico e con agenti fisici. Relaz. XIII Congr. Soc. intern. Urol., Londra 1964.
236.
RavasiniG.: Tumori epiteliali della vescica. Sintomatologia, diagnosi, terapia.Atti Soc. It. Cancerol., Padova1960.
237.
ReesR. W. M.: The effect of transurethral resection of the intravesical ureter during the removal of bladder tumours. Read at the twenty-fourth Annual Meeting of the Brit. Ass. Urol. Surg, at Cardiff, 1968. Brit. J. Urol., 41; 2–5 (1969).
238.
ReesR. W. M.: The effect of transurethral resection of the intravesical ureter during the removal of bladder tumours. Read at 24th Annual Meeting of the Brit. Ass. Urol. Surgeons at Cardiff, 1968. Brit. J. Urol., 41; 2 (1969).
239.
ResuikM. I., O'ConnorV. J.Jr.: Segmental resection for carcinoma of the bladder: review of 102 patients. J. Urol., 109; 1007 (1973).
240.
RiboliE.: Epidemiologia ed etiopatogenesi. Relazione al 22° Corso superiore di Oncologia Clinica: I tumori urologici, Milano 19 Maggio 1981.
241.
RichesE.: Choice of treatment in carcinoma of the bladder. J. Urol., 84; 472 (1960).
242.
RichieJ. P., SkinnerD. G., KaufmannJ. J.: Carcinoma of the bladder; treatment by radical cystectomy. J. Surg. Res., 18; 271 (1975).
243.
RichieJ. P., SkinnerD. G., KaufmanJ. J.: Radical cystectomy for carcinoma of the bladder: 16 years of experience. J. Urol., 113; 186 (1975).
244.
RichieJ. P., SkinnerD. G., KaufmanJ. J.: Carcinoma of the bladder: treatment by radical cystectomy. J. Surg. Res, 18; 271–275 (1975).
245.
RichieP. J., SkiunderD. G.: Carcinoma in situ of the urethra associated with bladder carcinoma: the role of urethrectomy. J. Urol., 119; 80–81 (1978).
246.
RigondetG., BartheCh.: Les risques du traitement endoscopique des tumeurs papillaires situées au voisinage des orifices urétéraux. J. d'Urol, 80; 693–696 (1974).
247.
Rocca RossettiS.: Trattamento integrato del carcinoma della vescica CNR 08179/N. Progetto finalizzato «Controllo della crescita neoplastica, sottoprogetto terapie associate». Milano 1981.
248.
Rocca RossettiS.: Indicazioni chirurgiche: T.U.R., cistectomia parziale, cistectomia totale. Atti 22° Corso superiore di Oncologia Clinica: I tumori urologici. Milano 19 Maggio 1981.
249.
Rocca RossettiS.: Transurethral surgery.Corso di Urologia, Erice1978.
250.
Rocca RossettiS.: Indications for cistectomy.Corso di Urologia, Erice1978.
251.
RizzoF. P.: Chemioterapia topica e chemioprofilassi delle neoplasie vescicali. In: The tumours of genito-urinary apparatus, p. 215–227. Erice 1976, Edited by Pavone-MacalusoM.COFESE, Palermo1977.
252.
Romero AguirreF.: Resección transuretral de los tumores del tracto urinario inferior. In: Curso sobre neoplasias urologicas, p. 203. Guillot ed, Madrid1977.
253.
RoperB. A., SmithJ. C.: Vesico-ureteric reflux following operations on the ureteric orifice. Brit. J. Urol, 37; 531–535 (1965).
254.
RübbenH., LutzeyerW., RubenzenJ.: Therapy of urothelial bladder tumors. Results of a retrospective study of 615 cases. Eur. Urol, 5; 1 (1979).
255.
RübbenH., LutzeyerW., RubenzenJ.: Therapy of urothelial bladder. Results of a retrospective study of 615 cases. Eur. Urol, 5; 1–6 (1979).
256.
SamelleW., HebermenH.: Vesico-ureteral reflux following electroresection of the prostate or bladder tumor. J. Urol, 96; 174 (1966).
257.
SchadeR. O. K., SwinneyJ.: The association of urothelial atypism with neoplasia: tis importance and prognosis. J. Urol, 109; 619–622 (1973).
258.
SchadeR. O. K., SwinneyJ.: Precancerous changes in bladder epithelium. Lancet, 2; 943 (1968).
259.
SchadeR. O. K., SerckHaussen A, SwinneyJ.: Morphological changes in the ureter in cases of bladder carcinoma. Cancer, 27; 1267 (1971)
260.
SchoborgT. W., SaplskyJ. L., LewisC. W.Jr.: Carcinoma of the bladder treated by segmental resection. J. Urol, 122; 473–475 (1979).
261.
SesiaG., UbertiE., LandiM., De ZenA.: Risultato del trattamento dei tumori vescicali. Minerva urol, 26; 221–237 (1974).
262.
SesiaG., FerrandoU., PaglianoG., ChiaudanoC.: Generalità, indicazioni, tecnica e complicazioni della terapia iperbarica nelle neoplasie vescicali. Urologia, 47; 978 (1980).
263.
ShortJ. G.: Hypertermia and cancer: a brief review of its history, status and potential.Biomatic. Euromarket Co.1980.
264.
ShortJ. G., TurnerP. F.: Physical hypertermia and cancer therapy. Prof.’ IEEE, 68; 133–142 (1980).
265.
SkinnerD. G., RichieJ. P., CooperP. H., WaismanJ., KaufmanJ. J.: Clinical significance of carcinoma in situ of the bladder and its association with overt carcinoma. J. Urol, 112; 68 (1974).
266.
SilverbergerE.: Cancer statistics 1978. Cancer, 28; 17 (1978).
267.
SlackN. H., ProutG. R.Jr.: The heterogeneity of invasive bladder carcinoma and different responses to treatment. J. Urol., 123; 644–652 (1980).
268.
SlavikM.: Adriamycin (NSC-123127) activity in genitourinary and gynecologic malignancies. Cancer Chemother. Rep., 6; 297–303 (1975).
269.
SmithP. H.: Chemotherapy of bladder cancer. In: The tumours of genito-urinary apparatus, p. 241–248. Erice, 1976, ed. by Pavone-MacalusoM., COFESE, Palermo1977.
270.
SobinL. H.: The WHO istological classification urinary bladder. Urol. Res., 6; 193–195 (1978).
271.
SolowayM. S.: Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res., 37; 2918–2988 (1977).
272.
SolowayM. S.: Urothelial neoplastic cellular implantation. Intravesical and systemic chemotherapeutic prophylaxis. Proc. Amer. Assoc. Cancer Res., 16; 17 (1975).
273.
SolowavM. S., MurphyW., RaoM. K., CoxC.: Serial multiple site biopsies in patients with bladder cancer. J. Urol., 120; 57 (1978).
274.
SotoE. A., FriedellG. H., TiltmanA. J.: Bladder cancer as seen in giant histologic sections. Cancer, 39; 447 (1977).
275.
StaehlerG., HofstetterA., GorishW., KeiditschE., MüssiggangM.: Endoscopy in experimental urology using an argon Laser beam. Endoscopy, 8; 1–4 (1976).
276.
StegA., DebréB., MonneinsF., DraoniD.: Le cancer de la vessie «in situ»; à propos de 10 cases. J. d'Urol, 84; 576–582 (1978).
277.
StegA.: Conduit à tenir dévant une tumeur infiltrante de vessie. 81e Congrès. Français Chir., p. 141–144. Masson éd., Paris1979.
278.
StewertB. H., NovickS. S.: Current perspective on palliative therapy in cancer of bladder. Cancer Res., 37; 2781–2788 (1977).
279.
TestutL., JacobO.: Trattato di Anatomia Topografica, vol. III, p. 103–104. Utet, Torino1968.
280.
ThubaultPh., TenaillonM., RolandJ., ValadeS., GattegnoB., ScbteonV.: Évolution des tumeurs papillaires de vessie respectant la musculeuse. J. d'Urol., 85; 709–713 (1979).
281.
ThompsonG. J.: Cystoscopic control of tumors of the urinary bladder. In: Treatment of cancer and allied diseases.PackG. T. and ArielI. M. ed., Harper & Row, New York1962.
282.
ThompsonG. J., KaplanJ. H.: Advantages of transurethral removal of certain bladder tumors. J. Urol., 73; 270 (1955).
283.
ToniniG. M.: La terapia endoscopica dei tumori vescicali: tipica affezione della senescenza. Relazione alle 10° Sintesi Mediche Attuali di «Rinnovamento Medico», Padenghe del Garda, 22–23 Giugno 1974.
284.
ToniniG. M., Pasetti BombardellaM., BonannoA., FerranteA.: Valore e limiti della chirurgia endoscopica nelle neoplasie vescicali. Urologia, 43; (1976).
285.
TorchianaB., BenelliR., CoveriP., FioriniA.: La nostra esperienza sul trattamento endoscopico della papillomatosi vescicale. Atti 49° Congr. S.I.U., Ferrara 1976.
U.I.C.C.: TNM classification of malignant tumours. Bladder, Third edition, Geneva 1978.
288.
Union Internationale contre le cancer: TNM classification of malignant tumoursWHO.Geneva1973.
289.
UtzD. C., HanashK. A., FarrowG. N.: The plight of the patient with carcinoma in situ of the bladder. J. Urol., 130; 160 (1970).
290.
UtzD. C., SchmitzS. E., FulgelsoP. D., FarrowG. M.: A clinico-pathologic evaluation of partial cystectomy for carcinoma of the urinary bladder. Cancer, 32; 1075 (1973).
291.
UtzD. C., ZinckeH.: The masquerade of bladder cancer in situ as interstitial cistitis. J. Urol., Ill; 161 (1974).
292.
Van der Werf-MessingB.: Carcinoma of the bladder treated by preoperative irradiation followed by cystectomy: the second report. Cancer, 32; 1084–1088 (1973).
293.
Van der Werf-MessingB.: Carcinoma vesicae treated at the Rotterdam Radiotherapy Institute between 1950 and 1974, p. 55–56. Erasms University, Rotterdam1975.
VinnicombeJ., AbercrombieG. F.: Total cystectomy. A review. Brit. J. Urol., 50; 488–491 (1978).
299.
VivilleCh.: Les complications de la résection endoscopique. Atti 37° Congr. Soc. Belg. Urol., Bruxelles 2–4 Giugno 1972. Acta Urol. Belgica, 41; 93–94 (1973).
300.
VivilleCh., PascoetG., ThomasM.: Le traitment des papillomes de la vessie par résection endoscopique. Lyon chir., 69; 181–185 (1973).
301.
WallaceD. M., HindmarshJ. R., WebbJ. M., BusuttilA., HargreaveT. B., NewsamJ. E., ChisolmG. D.: The role of multiple mucosal biopsies in the management of patients with bladder cancer. Brit. J. Urol., 51; 535–540 (1979).
302.
WallaceD. M., BloomH. J. G.: The management of deeply infiltrating (T3) bladder carcinoma. Brit. J. Urol., 48; 587–594 (1976).
303.
WallaceD. M., ChisolmG. D., HendryW. F.: TNM Classification for urological tumours (VICC) 1974. Brit. J. Urol., 47; 1–12 (1975).
WeldonT. E., SolowayM. S.: Susceptibility of urothelium to neoplastic cellular implantation. Urology, 5; 824–827 (1975).
309.
WeyrauchH. M., BassetJ. B., BergerN. M.: Practical considerations in the use of high frequency currents for transurethral prostatectomy. J. Urol., 61; 371–383 (1949).
310.
WhitmoreW. F.Jr., MarshallV. F.: Radical surgery for carcinoma of the urinary bladder. Cancer, 9; 596–608 (1956).
311.
WhitmoreW. F.Jr., MarshallV. F.: Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J. Urol., 87; 835 (1975).
312.
WhitmoreW. F.Jr., BatataM. A., HilarisB. S., ReddyG. N., UnalA., GhoneimM. A., GrabstaldH., ChanF.: A comparative study of two preoperative radiation regimens with cystectomy for bladder cancer. Cancer, 40; 1077–1086 (1977).
313.
WhitmoreW. F.Jr., BatataM. A., GouheimM. A., GrabstaldH., UnalA.: Radical cystectomy with or without prior irradiation in the treatment of bladder cancer. J. Urol., 118; 184–187 (1977).
314.
WithmoreW. F.Jr.: Summary of all phases of bladder carcinoma. J. Urol., 119; 77–79 (1978).
WincqzP. J., VerbistR.: Les complications de la résection endoscopique. Atti 37° Congr. Soc. Belga Urol., Bruxelles 2–4 Giugno 1972. Acta Urol. Belgica, 41; 78–81 (1973).
317.
XerryA., AuvertJ.: Complications des résections endoscopiques. Atti 37° Congr. Soc. Belga Urol., 2–4 giugno 1972. Acta Urol. Belgica, 41; 68–73 (1973).
Yates - BellA. J.: Carcinoma in situ of the bladder. Brit. J. Surg., 58; 359 (1971).
320.
YoungH. H.: Clinical work-up and evaluation of the patients with bladder tumours. In: Pavone-Macaluso: The tumours of genito-urinary apparatus, p. 175–177. COFESE, Palermo1977.
321.
ZinggE.: Blasenkarzinom: Heutiger Stand der Therapie. Schweiz. Rundschau Med. (Praxis).64; 1550–1552 (1975).
322.
Zolfa-nelliR., BerasoloE., VenturaM.: La distensione vescicale nel trattamento delle neoplasie incurabili della vescica. Urologia, 47; 995 (1980).